A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers
Clinical trial NCT01853722 · COMPLETED
Trial details
- NCT number
- NCT01853722
- Sponsor
- Deacon Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2013-07-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.